These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 6265890

  • 1. Effect of combined treatment with dopaminergic and GABA-ergic drugs on the threshold for maximal electroconvulsions in mice.
    Czuczwar SJ.
    Pol J Pharmacol Pharm; 1981; 33(1):25-35. PubMed ID: 6265890
    [Abstract] [Full Text] [Related]

  • 2. Effect of combined GABA-ergic and dopaminergic stimulation on the action of some antiepileptic drugs in pentetrazol-induced convulsions.
    Kleinrok Z, Czuczwar SJ, Kozicka M, Zarkowski A.
    Pol J Pharmacol Pharm; 1981; 33(1):13-23. PubMed ID: 6265889
    [Abstract] [Full Text] [Related]

  • 3. Effect of dopaminergic and GABA-ergic drugs given alone or in combination on the anticonvulsant action of phenobarbital and diphenylhydantoin in the electroshock test in mice.
    Kleinrok Z, Czuczwar SJ, Kozicka M.
    Epilepsia; 1980 Oct; 21(5):519-29. PubMed ID: 6252007
    [Abstract] [Full Text] [Related]

  • 4. Effects of gamma-aminobutyric acid (GABA) receptor agonists on the neurotoxicity and anticonvulsant activity of barbiturates in mice.
    Ulloque RA, Chweh AY, Swinyard EA.
    J Pharmacol Exp Ther; 1986 May; 237(2):468-72. PubMed ID: 3009786
    [Abstract] [Full Text] [Related]

  • 5. Interactions of angiotensin II and GABA-ergic agents at the threshold of convulsive reactions.
    Georgiev VP, Petkova BP, Petkov VD, Kambourova TS.
    Acta Physiol Pharmacol Bulg; 1986 May; 12(2):14-20. PubMed ID: 3020873
    [Abstract] [Full Text] [Related]

  • 6. The effect of baclofen and aminooxyacetic acid on the action of drugs stimulating the dopaminergic system.
    Sypniewska M.
    Pol J Pharmacol Pharm; 1978 May; 30(6):755-66. PubMed ID: 573471
    [Abstract] [Full Text] [Related]

  • 7. GABA-ergic mechanisms in the anticonvulsive activity of newly synthesized barbiturates. II. Correlation of HB-7 with GABA-ergic agents.
    Getova D, Georgiev V.
    Acta Physiol Pharmacol Bulg; 1988 May; 14(2):49-55. PubMed ID: 2851914
    [Abstract] [Full Text] [Related]

  • 8. Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
    Markovska V, Georgiev V.
    Acta Physiol Pharmacol Bulg; 1982 May; 8(3):67-73. PubMed ID: 6820612
    [Abstract] [Full Text] [Related]

  • 9. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
    Worms P, Depoortere H, Durand A, Morselli PL, Lloyd KG, Bartholini G.
    J Pharmacol Exp Ther; 1982 Mar; 220(3):660-71. PubMed ID: 6278129
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission.
    Georgiev VP, Markovska VL, Petkova BP.
    Acta Physiol Pharmacol Bulg; 1978 Mar; 4(3):56-64. PubMed ID: 220843
    [Abstract] [Full Text] [Related]

  • 12. [Dopaminergic component in the mechanism of action of gamma-aminobutyric acid derivatives and structural analogs].
    Allikmets LKh, Polevoĭ LG, Tsareva TA, Zharkovskiĭ AM.
    Farmakol Toksikol; 1979 Mar; 42(6):603-6. PubMed ID: 499466
    [Abstract] [Full Text] [Related]

  • 13. [Convulsions induced by kynurenine and quinolinic acid as a sensitive test for assessing the anticonvulsant activity of GABA-ergic preparations].
    Lapin IP, Ryzhov IV.
    Biull Eksp Biol Med; 1983 Apr; 95(4):53-5. PubMed ID: 6299432
    [Abstract] [Full Text] [Related]

  • 14. The influence of sodium gamma-hydroxybutyrate on GABA receptors and catecholamine effect potentiation.
    Kozhechkin SN.
    Arch Int Pharmacodyn Ther; 1981 Apr; 250(2):242-53. PubMed ID: 6268008
    [Abstract] [Full Text] [Related]

  • 15. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ, György L.
    Acta Physiol Acad Sci Hung; 1981 Apr; 58(3):225-33. PubMed ID: 7348023
    [Abstract] [Full Text] [Related]

  • 16. [Correlation of dopamin- and GABA-ergic mechanisms in the depressive effect of neuroleptics on pedal self-stimulation of the ventral tegmentum of the mesencephalon].
    Talalaenko AN, Boreĭsha IK.
    Farmakol Toksikol; 1983 Apr; 46(2):36-9. PubMed ID: 6133777
    [Abstract] [Full Text] [Related]

  • 17. Involvement of transmitter mechanisms in the behavioural effects of angiotensin II.
    Georgiev V.
    Pol J Pharmacol Pharm; 1990 Apr; 42(6):553-62. PubMed ID: 1983291
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of GABA analogues on blood pressure and central GABA metabolism in the rat.
    Persson B, Henning M.
    Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):135-43. PubMed ID: 7435198
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.